News | December 15, 2022
China aims to lead next bio revolution in advanced biologics, says GlobalData
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
Construction is now underway with the facility scheduled to be operational by 2025
Subscribe To Our Newsletter & Stay Updated
